Su4312 represses glioma progression by inhibiting yap and inducing sensitization to the effect of temozolomide

HIGHLIGHTS

• who: Xu Wang et al. from the Institute of Nervous System Diseases, Xuzhou Medical University, West Huaihai Road, Xuzhou, China have published the research work: SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide, in the Journal: (JOURNAL) of 16/08/2022
• what: The authors report that inhibited glioma cell proliferation and down-regulated yes-associated protein (YAP) the key effector of the hippo pathway. The authors investigated the effect of SU4312 on glioma progression, both in_vitro and in_vivo.
• how: The results showed that SU4312 inhibited the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.